Glen Apseloff

1.5k total citations
55 papers, 1.1k citations indexed

About

Glen Apseloff is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Physiology. According to data from OpenAlex, Glen Apseloff has authored 55 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 10 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Glen Apseloff's work include Pharmacogenetics and Drug Metabolism (7 papers), Opioid Use Disorder Treatment (5 papers) and Pain Management and Opioid Use (4 papers). Glen Apseloff is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Opioid Use Disorder Treatment (5 papers) and Pain Management and Opioid Use (4 papers). Glen Apseloff collaborates with scholars based in United States, Canada and United Kingdom. Glen Apseloff's co-authors include Nicolas Gerber, Keith D. Wilner, D. Mullet, Dale R. Shepard, H. Friedman, Gary D. Stoner, Christine Sardo, J. Miceli, Alpana Singh and Xiaoli Sun and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Glen Apseloff

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Glen Apseloff United States 21 190 151 142 141 125 55 1.1k
Keri Wellington New Zealand 26 329 1.7× 172 1.1× 170 1.2× 120 0.9× 225 1.8× 54 1.9k
Aysun Bay Karabulut Türkiye 26 301 1.6× 60 0.4× 317 2.2× 270 1.9× 187 1.5× 125 2.0k
Mark A. Moyad United States 25 276 1.5× 94 0.6× 279 2.0× 157 1.1× 37 0.3× 119 1.6k
Faruk Öktem Türkiye 19 164 0.9× 61 0.4× 93 0.7× 106 0.8× 73 0.6× 49 1.3k
Rogelio Troyo‐Sanromán Mexico 17 181 1.0× 47 0.3× 148 1.0× 99 0.7× 107 0.9× 56 930
Stacey J. Bell United States 17 190 1.0× 71 0.5× 101 0.7× 385 2.7× 40 0.3× 66 1.6k
Katharina Schroecksnadel Austria 22 325 1.7× 209 1.4× 112 0.8× 225 1.6× 53 0.4× 44 1.6k
Vinod Kochupillai India 23 293 1.5× 37 0.2× 208 1.5× 116 0.8× 118 0.9× 110 1.8k
Kesavan Ramasamy India 9 178 0.9× 59 0.4× 69 0.5× 78 0.6× 149 1.2× 34 937
Maria das Graças Almeida Brazil 24 305 1.6× 40 0.3× 80 0.6× 159 1.1× 51 0.4× 100 1.7k

Countries citing papers authored by Glen Apseloff

Since Specialization
Citations

This map shows the geographic impact of Glen Apseloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Apseloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Apseloff more than expected).

Fields of papers citing papers by Glen Apseloff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen Apseloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Apseloff. The network helps show where Glen Apseloff may publish in the future.

Co-authorship network of co-authors of Glen Apseloff

This figure shows the co-authorship network connecting the top 25 collaborators of Glen Apseloff. A scholar is included among the top collaborators of Glen Apseloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen Apseloff. Glen Apseloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cipriano, Alessandra, Ellie He, Manjunath S. Shet, Glen Apseloff, & Stephen Harris. (2025). Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene Administered by Auto‐Injector Versus Intranasal Naloxone. The Journal of Clinical Pharmacology. 65(12). 1661–1675.
2.
Li, Yajuan, et al.. (2023). Pharmacokinetics and Tolerability of the Cancer-Targeting MRI Contrast Agent MT218 in Healthy Males. Investigative Radiology. 59(2). 165–169. 5 indexed citations
3.
4.
Sardo, Christine, Joseph P. Kitzmiller, Glen Apseloff, et al.. (2013). An Open-Label Randomized Crossover Trial of Lyophilized Black Raspberries on Postprandial Inflammation in Older Overweight Males. American Journal of Therapeutics. 23(1). e86–e91. 19 indexed citations
5.
Apseloff, Glen, Erol Onel, & Gary Patou. (2013). Time to onset of analgesia following local infiltration of liposome bupivacaine in healthy volunteers: a randomized, single-blind, sequential cohort, crossover study. International Journal of Clinical Pharmacology and Therapeutics. 51(5). 367–373. 19 indexed citations
6.
Harris, Stephen, et al.. (2010). Serum Transaminase Levels Should Be Measured Immediately Prior to Dosing in Early Phase I Clinical Trials. The Journal of Clinical Pharmacology. 51(2). 252–255. 1 indexed citations
7.
Tishler, Carl L., et al.. (2007). Are normal healthy research volunteers psychologically healthy? A pilot investigation.. Experimental and Clinical Psychopharmacology. 15(6). 539–545. 6 indexed citations
8.
Cotreau, Monette, Vargheese M. Chennathukuzhi, Heather A. Harris, et al.. (2007). A study of 17β-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas. 58(4). 366–376. 34 indexed citations
9.
Apseloff, Glen. (2002). HIV Testing in Early Clinical Trials: Who Should Decide Whether It Is Warranted?. The Journal of Clinical Pharmacology. 42(6). 601–604. 1 indexed citations
10.
Shah, Ajit, et al.. (2001). Pharmacokinetics and Safety of Oral Eletriptan during Different Phases of the Menstrual Cycle in Healthy Volunteers. The Journal of Clinical Pharmacology. 41(12). 1339–1344. 16 indexed citations
11.
Apseloff, Glen, et al.. (2000). Practical Considerations Regarding the Influence of the Menstrual Cycle on Leukocyte Parameters in Clinical Trials. American Journal of Therapeutics. 7(5). 297–302. 10 indexed citations
12.
Apseloff, Glen, et al.. (1998). Comparison of Azithromycin and Clarithromycin in Their Interactions with Rifabutin in Healthy Volunteers. The Journal of Clinical Pharmacology. 38(9). 830–835. 30 indexed citations
13.
Apseloff, Glen, Keith D. Wilner, Nicolas Gerber, & Larry M. Tremaine. (1997). Effect of Sertraline on Protein Binding of Warfarin. Clinical Pharmacokinetics. 32(Supplement 1). 37–42. 35 indexed citations
14.
Orosz, Charles G., Sergio D. Bergese, Anne M. VanBuskirk, et al.. (1996). PREVENTION OF MURINE CARDIAC ALLOGRAFT REJECTION WITH GALLIUM NITRATE. Transplantation. 61(5). 783–791. 70 indexed citations
15.
Apseloff, Glen, et al.. (1996). Medical histories may be unreliable in screening volunteers for clinical trials. Clinical Pharmacology & Therapeutics. 60(3). 353–356. 20 indexed citations
16.
Mays, Dennis C., et al.. (1995). Metabolism of phenytoin and covalent binding of reactive intermediates in activated human neutrophils. Biochemical Pharmacology. 50(3). 367–380. 20 indexed citations
17.
Matkovic, Velimir, S. E. Weisbrode, Glen Apseloff, et al.. (1994). The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats. Bone and Mineral. 25(1). 59–69. 12 indexed citations
18.
Whitacre, Caroline C., Glen Apseloff, Karen L. Cox, et al.. (1992). Suppression of experimental autoimmune encephalomyelitis by gallium nitrate. Journal of Neuroimmunology. 39(1-2). 175–181. 33 indexed citations
19.
Apseloff, Glen, Jay B. Hilliard, Nicolas Gerber, & D C Mays. (1991). Inhibition and induction of drug metabolism by psoralens: Alterations in duration of sleep induced by hexobarbital and in clearance of caffeine and hexobarbital in mice. Xenobiotica. 21(11). 1461–1471. 8 indexed citations
20.
Apseloff, Glen, et al.. (1991). Induction of Fluconazole Metabolism by Rifampin: In Vivo Study in Humans. The Journal of Clinical Pharmacology. 31(4). 358–361. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keri Wellington Breakdown of academic impact, for papers by Aysun Bay Karabulut Breakdown of academic impact, for papers by Mark A. Moyad Breakdown of academic impact, for papers by Faruk Öktem Breakdown of academic impact, for papers by Rogelio Troyo‐Sanromán Breakdown of academic impact, for papers by Stacey J. Bell Breakdown of academic impact, for papers by Katharina Schroecksnadel Breakdown of academic impact, for papers by Vinod Kochupillai Breakdown of academic impact, for papers by Kesavan Ramasamy Breakdown of academic impact, for papers by Maria das Graças Almeida
Rankless by CCL
2026